Navigation Links
MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
Date:3/5/2010

ATLANTA, March 5 /PRNewswire/ -- MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPHIX ™ Shape Memory Suture Anchor.  The MORPHIX device was developed with financial assistance through NIH/NIAMS Grants # 1R43AR056154-01, 2R44AR056154-02, 5R44AR056154-03.  The MORPHIX Anchor is being highlighted and launched nationally at the American Academy of Orthopedic Surgeons meeting in New Orleans, March 10-13, 2010.

The Small Business Act Policy Directive provides that "Government owned, contractor operated facilities….give preference including sole source awards to the awardee that developed the technology."  Section 4 (c) (7)  The Directive also states that "the competition for SBIR Phase I and Phase II awards satisfies any competition requirement of the Armed Services Procurement Act, The Federal Property and Administrative Services Act and the Competition in Contracting Act."  Section 4 (c) (3)

"The development of the MORPHIX Suture Anchor with SBIR support was a textbook case of how a partnership in development should occur.  The grant funding received was critical to the development success and eventual commercialization of this innovative technology," stated Chris Fair, Chief Operations Officer of MedShape Solutions.

MedShape Solutions initial product is the MORPHIX Suture Anchor made from proprietary shape memory PEEK Altera.   "We anticipate releasing additional technologies in the months ahead that were  supported via SBIR Phase I & Phase II awards for their development.  These technologies will also receive the same preferred supplier status within their product category," stated Kurt Jacobus, PhD, President & CEO of MedShape Solutions.

MedShape Solutions is a privately held company focused on developing orthopedic devices from proprietary shape memory technology.  You may find more information at www.medshape.com.

If you are a government purchasing group and would like additional information, please contact Chris Fair, Chief Operating Officer of MedShape Solutions at (404) 249-9155 or send an email to gov@medshape.com .

SOURCE MedShape Solutions, Inc.

Back to top

RELATED LINKS
http://www.medshape.com

'/>"/>

SOURCE MedShape Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
2. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
3. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
4. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
5. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
6. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
7. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
8. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
9. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
10. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
11. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... WonderWorks, Myrtle Beach’s science focused amusement ... of deep space exploration and inspire space enthusiasts. The exhibit features interactive exhibits ... guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic weekend kicks ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call ... healthcare industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- ... in Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/24/2017)... , April 24, 2017  Dante Labs announced today the ... EUR 850 (ca. $900). While American individuals have been able ... time Europeans can access WGS below EUR 1,000. ... to leveraging genetic information to make informed decisions about disease ... ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):